Aurinia Pharmaceuticals
AUPH
#4586
Rank
HK$16.26 B
Marketcap
HK$123.39
Share price
1.54%
Change (1 day)
73.72%
Change (1 year)

Aurinia Pharmaceuticals (AUPH) - Total debt

Total debt on the balance sheet as of September 2025 : HK$0.60 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's total debt is HK$0.60 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Aurinia Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.61 B-19.17%
2023-12-31HK$0.76 B1106.32%
2022-12-31HK$63.19 M-7.26%
2021-12-31HK$68.14 M4.56%
2020-12-31HK$65.17 M
2019-12-31N/A
2013-12-31N/A-100%
2012-12-31HK$0.28 M-54.48%
2011-12-31HK$0.61 M
2008-12-31HK$99.53 M1753.7%
2007-12-31HK$5.36 M-70.42%
2006-12-31HK$18.15 M-40.93%
2005-12-31HK$30.73 M-18.81%
2004-12-31HK$37.85 M1049.41%
2003-12-31HK$3.29 M62.56%
2002-12-31HK$2.02 M102.76%
2001-12-31HK$0.99 M
2000-11-30HK$0.82 M-21.51%
1999-11-30HK$1.05 M-47.68%
1998-11-30HK$2.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$21.04 B 3,359.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
HK$13.12 M-97.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
HK$95.63 M-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA